DrugPatentWatch Database Preview
Medexus Company Profile
» See Plans and Pricing
What is the competitive landscape for MEDEXUS, and when can generic versions of MEDEXUS drugs launch?
MEDEXUS has one approved drug.
There is one US patent protecting MEDEXUS drugs.
There are twenty-five patent family members on MEDEXUS drugs in twenty-one countries.
Summary for Medexus
| International Patents: | 25 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Medexus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medexus | RASUVO | methotrexate | SOLUTION;SUBCUTANEOUS | 205776-005 | Jul 10, 2014 | RX | Yes | Yes | 8,664,231 | Start Trial | Start Trial | ||||
| Medexus | RASUVO | methotrexate | SOLUTION;SUBCUTANEOUS | 205776-001 | Jul 10, 2014 | RX | Yes | Yes | 8,664,231 | Start Trial | Start Trial | ||||
| Medexus | RASUVO | methotrexate | SOLUTION;SUBCUTANEOUS | 205776-008 | Jul 10, 2014 | RX | Yes | Yes | 8,664,231 | Start Trial | Start Trial | ||||
| Medexus | RASUVO | methotrexate | SOLUTION;SUBCUTANEOUS | 205776-002 | Jul 10, 2014 | RX | Yes | Yes | 8,664,231 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Medexus Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Germany | 102006033837 | Start Trial |
| Spain | 2355399 | Start Trial |
| Austria | 14872 | Start Trial |
| Japan | 5683810 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
